招聘
必备技能
Go
Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care.
We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges.
GRAIL is headquartered in the bay area of California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies.
For more information, please visit grail.com
This is a great opportunity to join the growing commercial team at GRAIL, as a GRAIL Galleri Consultant (GGC1), working hand in hand with sales leadership and internal stakeholders to execute the go to market sales strategy for GRAIL’s revolutionary MCED (multi-cancer early detection) product Galleri. https://www.galleri.com/
This is a customer-focused position that requires a “market builder” mindset. A successful GGC1 acts with urgency and passion to engage physicians and their staff to think differently about cancer screening and change the way they practice, integrating MCED technology into their office workflow, and consistently offering it to appropriate patients with the goal to identify more cancers sooner.
GRAIL is the first company in the world to bring MCED technology to patients and clinicians - this is a rare opportunity in one's career!
The GGC1 role is an in-person selling role, with the expectation that candidates spend the majority of their time (>85%) making in-person visits to targeted physician practices, planning and supporting events, and executing on Company initiatives.
This is a field-based role located in your city and state, currently covering the following territory: Modesto, Merced, Fresno, Visalia, Porterville, Bakersfield and surrounding areas. While you will primarily operate in the field, travel to a GRAIL office or other locations may be required to support business needs.
We’re building a world-class team to take on one of healthcare’s most important challenges. Are you ready to join us?
总浏览量
0
申请点击数
0
模拟申请者数
0
收藏
0
相似职位

Mission Operations Master, MUSV
Saronic · Austin, TX

Intermediate Multi-Asset Analyst
Allstate · Chicago River Point

Campground Set-Up Crew - The Gorge Amp.
Live Nation · George, WA, USA

Madison Runner
Live Nation · Madison, WI, USA

Master Class - Business Consultant - Life Sciences R&D (Germany)
Veeva Systems · Germany - Berlin
关于Grail

Grail
Series CGRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
201-500
员工数
Menlo Park
总部位置
$3.2B
企业估值
评价
3.9
10条评价
工作生活平衡
3.8
薪酬
3.5
企业文化
4.2
职业发展
3.0
管理层
3.2
72%
推荐给朋友
优点
Good work-life balance
Supportive team and management
Innovative and challenging projects
缺点
Heavy workload and overwhelming at times
Limited career advancement opportunities
Management and communication issues
薪资范围
135个数据点
Junior/L3
Mid/L4
Senior/L5
Director
Junior/L3 · Operations Engineer 2
1份报告
$103,500
年薪总额
基本工资
$90,000
股票
-
奖金
-
$103,500
$103,500
面试经验
4次面试
难度
2.8
/ 5
时长
14-28周
体验
正面 25%
中性 75%
负面 0%
面试流程
1
Application Review
2
Recruiter Screen
3
Technical Phone Screen
4
Onsite/Virtual Interviews
5
Team Matching
6
Offer
常见问题
Technical Knowledge
Behavioral/STAR
Past Experience
Coding/Algorithm
新闻动态
GRAIL (NASDAQ: GRAL) outlines CEO transition, director elections in 2026 proxy - Stock Titan
Stock Titan
News
·
6d ago
My Grail Everyday Watch Gets the Perfect Summer Revamp - Gear Patrol
Gear Patrol
News
·
6d ago
Lilly's $2.25B bet chases genetic medicine's 'holy grail' - FirstWord Pharma
FirstWord Pharma
News
·
6d ago
Lilly, AI biotech Profluent ink $2.25B pact in search of genetic medicine ‘holy grail’ - BioSpace
BioSpace
News
·
6d ago